iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
2,259.1
(-5.60%)
May 22, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

23/04/2026calendar-icon
23/05/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

22-Apr-2026

2,233.1

2,2472,204.82,24018,32271,86,85,3311,55,110

23-Apr-2026

2,247.9

2,359.42,212.12,33584,5873,94,35,63,6784,68,479

24-Apr-2026

2,351

2,372.82,283.22,299.551,2541,94,83,53,615.42,75,925

27-Apr-2026

2,312

2,339.92,290.92,325.127,5011,07,14,29,887.51,79,514

28-Apr-2026

2,328.1

2,427.42,327.32,403.769,8963,69,11,62,502.96,11,689

29-Apr-2026

2,418.7

2,4742,403.72,413.943,0321,49,94,20,411.72,46,710

30-Apr-2026

2,400.1

2,455.92,385.62,406.339,2461,91,33,43,263.43,85,547

04-May-2026

2,434.3

2,438.82,382.62,393.738,6641,08,67,68,505.12,25,562

05-May-2026

2,384.3

2,4302,3602,417.960,7782,20,82,28,239.84,79,715

06-May-2026

2,435

2,4402,354.92,377.654,8272,67,33,47,240.24,62,629

07-May-2026

2,390

2,4042,355.72,371.632,5751,01,55,43,947.61,93,509

08-May-2026

2,350

2,384.92,315.82,366.449,3271,65,31,42,554.12,85,798

11-May-2026

2,356.5

2,368.82,317.72,347.338,4531,94,51,06,949.54,88,497

12-May-2026

2,340.9

2,340.92,2442,257.139,1231,73,29,98,8194,38,935

13-May-2026

2,245.2

2,326.52,245.22,277.639,6502,32,68,30,237.95,48,882

14-May-2026

2,300

2,350.42,292.62,340.642,7762,25,26,13,917.34,78,398

15-May-2026

2,345.9

2,367.92,317.12,325.923,23460,13,75,114.11,01,498

18-May-2026

2,329.7

2,353.32,3012,339.928,3671,00,05,55,074.42,00,838

19-May-2026

2,351.5

2,413.52,3352,405.945,1362,04,33,72,168.34,54,611

20-May-2026

2,410.2

2,4272,3702,37960,5732,32,94,62,061.34,54,328

21-May-2026

2,395

2,407.82,3722,39324,00891,34,79,183.81,50,723

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.